Two Sigma Securities »

Transcode Therapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $13k 13k 1.01
2024-03-31 $15k 22k 0.68

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Transcode Therapeutics

Geode Capital Management
Sheets Smith Wealth Management
Jane Street
Private Capital Management
Captrust Financial Advisors
Two Sigma Securities
Morgan Stanley
Tower Research Capital
Bank of America Corporation

View all funds holding Transcode Therapeutics